Argent BioPharma Limited (ASX:RGT)
Australia · Delayed Price · Currency is AUD 0.0370
0.00 (0.00%)
Jun 26, 2026, 3:44 PM AEST
Argent BioPharma Market Cap
Argent BioPharma has a market cap or net worth of 4.11 million as of June 26, 2026. Its market cap has decreased by -36.72% in one year.
Market Cap
4.11M
Enterprise Value
10.18M
Revenue
347.78K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.04
Market Cap Chart
Since September 28, 2012, Argent BioPharma's market cap has increased from 3.12M to 4.11M, an increase of 31.87%. That is a compound annual growth rate of 2.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2026 | 4.11M | -29.57% |
| Dec 31, 2025 | 5.84M | -36.74% |
| Dec 31, 2024 | 9.23M | -46.77% |
| Dec 29, 2023 | 17.33M | -45.96% |
| Dec 30, 2022 | 32.07M | -67.88% |
| Dec 31, 2021 | 99.85M | 123.36% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Syntara | 37.28M |
| Peak Processing | 19.73M |
| Vitura Health | 14.58M |
| IDT Australia | 14.11M |
| Epsilon Healthcare | 8.56M |
| ECS Botanics Holdings | 6.38M |
| Percheron Therapeutics | 6.09M |
| Cann Group | 4.88M |